Trademarks & Disclaimers

Registered or registration-pending trademarks of the QIAGEN Group:

QIAGEN®, Sample to Insight®, QIA®, QIAamp®, QIAamplifier®, QIAcard®, QIAcube®, QIAcuity®, QIAEX®, QIAexpress®, QIAGEN GeneRead®, QIAGEN GeneReader®, QIAgility®, QIAlab®, QIAlink®, QIAprep®, QIAprep&amp™, QIAGEN Quality®, QIAquant®, QIAquick®, QIAreach®, QIAscreen®, QIAseq®, QIAsphere®, QIAstat-Dx®, QIAsure™, QIAsymphony®, QIAwell®, QIAxcel®, QIAxpert®, QIAzol®, 4NS1C®, AllPrep®, Allprotect®, AllTaq®, artus®, AmniSure®, Autopure LS®, BioRobot®, BiOstic®, Bisulfitome®, BLU-V®, careHPV®, Certal®, Clotspin®, Cignal®, CLC bio®, CleanStart®, ClearMag®, CompactPrep®, CoralLoad®, CRISPR-Q™, DiagCORE®, digene®, DirectPrep®, DML 3000®, DNase Max®, DNeasy®, DyeEx®, EasiCollect®, EASYartus®, EasyXpress®, Effectene®, EndoFree®, EpiTect®, ESEQuant®, EZ1®, EZ2®, EZ1&2™, FastLane®, FastSelect™, FlexiGene®, FlexiTube®, FTA®, FusionChip®, FusionQuant®, GelPilot®, GeneGlobe®, Generation®, GeneRead®, GeneRead QIAcube®, GeneReader®, GeneSolution®, Gentra®, HC2®, HC2 High-Risk®, HC2 High-Risk HPV DNA Test®, HiCap®, HiPerFect®, HiSpeed®, HotStarTaq®, Hybrid Capture®, Ingenuity®, InhibitEX®, Inhibitor Removal Technology®, Investigator®, IPA®, ipsoAnalyzer®, ipsogen®, iReport®, LifeGuard®, LNA®, LyseBlue®, MagAttract®, Making improvements in life possible®, MaXtract®, mericon®, MinElute®, miRCURY®, miScript®, MutaQuant®, MutaSearch®, NeuMoDx®, NoviPure®, Oligotex®, Omniscript®, PartoSure®, PolyFect®, PowerBiofilm®, PowerClean®, PowerFecal®, PowerFood®, PowerLyzer®, PowerMag®, PowerMax®, PowerMicrobiome®, PowerPlant®, PowerSoil®, PowerViral®, PowerWater®, Premolecular®, Premolecular Diagnostics®, Prep&Amp™, ProfileQuant®, Puregene®, Pyro®, Pyrogram®, PyroMark®, Pyrosequencing®, Q-Bond®, Q‑Solution®, qBiomarker®, QCI®, QFM®, QFT®, QFT-Plus™, Qproteome®, QuantiFast®, QuantiFERON®, QuantiFERON Monitor®, QuantiNova®, Quantiscript®, Quantiplex®, QuantiProbe®, QuantiTect®, Rapid Capture®, R.E.A.L.®, REPLI-g®, RNAiFect®, RNAprotect®, RNeasy®, Rotor-Disc®, Rotor-Gene®, Rotor-Gene AssayManager®, RT2®, RT2 Profiler®, Scorpions®, ScreenClust®, ScreenGel®, Sensiscript®, SensiPhi®, SeqTarget®, SpeedXtract®, SpinClean®, STM®, SuperFect®, SwiftMag®, T-Script®, therascreen®, TissueRuptor®, TopTaq®, Transfac®, TransMessenger®, TurboCapture®, TurboFilter®, Type-it®, UltraClean®, Ultraplex®, UltraRun®, UltraSens®, Uni-Core®, Vapor-Lock®, WeLLevator®, XploreDNA®, XploreRNA®.

Other trademarks

2D Matrix® (Thermo Fisher Scientific or its subsidiaries); Abbott® (Abbott Laboratories); Abbott RealTime® (Abbott Laboratories); ABgene® (Thermo Fisher Scientific or its subsidiaries); ABI 5500 SOLiD™ (Life Technologies Corporation); ABI PRISM® (Life Technologies Corporation); Affymetrix® (Affymetrix, Inc.); Agilent® (Agilent Technologies, Inc.); Air-Mate™ (3M); ÄKTA® (GE Healthcare); Alexa Fluor® (Life Technologies Corporation); Amgen® (Amgen, Inc.); AmpFlstr® (Life Technologies Corporation); Apple® (Apple Computer, Inc.); Applied Biosystems® (Life Technologies Corporation); APTIMA® (Gen-Probe Incorporated); ATCC® (American Type Culture Collection); Avastin® (Genentech, Inc.); bactotype® (Indical Bioscience GMBH); BD™ (Becton Dickinson and Company); Benzonase® (Merck KGaA, Darmstadt, Germany); BigDye™ (Life Technologies Corporation); BioLogic™ (Bio-Rad Laboratories, Inc.); BioMag® (Polysciences Inc.); Bio-One® (Greiner Bio-One GmbH; Bio-Rad® (Bio-Rad Laboratories, Inc.); Bluetooth® (Blootooth SIG, Inc.); CDP-Star® (Life Technologies Corporation); CEQ™ (Beckman Coulter, Inc.); CLART® (Genomica S.A.U. Sociedad Anònima Unipersonal); cobas® (Roche Diagnostics Operations, Inc.); Coomassie® (ICI [Imperial Chemical Industries] Organics Inc.); Copan® (Copan Italia S.P.A.); Corning® (Corning, Inc.); CryoTube® (Thermo Fisher Scientific or its subsidiaries); Cy® (GE Healthcare); DACRON® (Invista North America S.A.R.L. Corporation); DAPase™ (UNIZYME); DART™ (Genome Diagnostics); DeepWell™ (Thermo Fisher Scientific or its subsidiaries); DYEnamic™ (GE Healthcare); EasyXtal® (Molecular Dimensions, Inc.); eNAT™ (Copan Italia S.P.A.); eppendorf twin.tec® (Eppendorf AG); Eppendorf® (Eppendorf AG); ERBITUX® (ImClone LLC., a wholly-owned subsidiary of Eli Lilly and Company); Excel® (Microsoft Corporation); FACS® (Becton Dickinson and Company); Falcon® (Corning, Inc.); FAM™ (Life Technologies Corporation); FPLC® (GE Healthcare); GeneAmp® (Life Technologies Corporation); GeneChip® (Affymetrix, Inc.); GeneMapper® (Life Technologies Corporation); GeneReader™ (Intelligent Bio-Systems, Inc.); GeneScan® (Life Technologies Corporation); Genotyper® (Life Technologies Corporation); GILOTRIF® (Boehringer Ingelheim International GmbH); Hard-Shell® (Bio-Rad Laboratories, Inc.); HiSeq® (Illumina, Inc.); Horizon™ (Horizon Discovery Limited); iCycler iQ® (Bio-Rad Laboratories, Inc.); Identifiler® (Life Technologies Corporation); llumina® (Illumina, Inc.); Infinium® (Illumina, Inc.); Internet Explorer® (Microsoft Corporation); Ion PGM™ (Life Technologies Corporation); Ion Torrent™ (Life Technologies Corporation); iPad® (Apple Computer, Inc.); iPod nano® (Apple Computer, Inc.); iPod® (Apple Computer, Inc.); IRESSA® (AstraZeneca Group); iSeq® (Illumina, Inc.); J&J® (Johnson & Johnson); JOE™ (Life Technologies Corporation); K-Y® (Johnson & Johnson); KAPA® (Roche Group); KAPA Biosystems® (Roche Group); LIAISON® (DiaSorin); LightCycler® (Roche Group); Luminex® (Luminex Corporation); LyoSphere™ (BioLyph Inc.); LyoSpheres™ (BioLyph Inc.); March of Dimes® (March of Dimes Foundation) ; Mastercycler® (Eppendorf AG); MegaBACE™ (GE Healthcare); Merck® (Merck Sharp & Dohme Corp.); Merz® (Merz Pharma GmbH & Co. KGaA); MethylScreen™ (Orion Genomics, LLC); Metrogel® (Galderma S.A.); MGB™ (Epoch Biosciences); MicroAmp® (Life Technologies Corporation); Microgard™ (Becton Dickinson and Company); Micronic™ (Micronic Holding B.V.); Microsoft® (Microsoft Corporation); Microtainer® (Becton Dickinson and Company); MiniSeq® (Illumina, Inc.); MiSeq® (Illumina, Inc.); Monistat® (Johnson & Johnson); MVS® (Artel, Inc.); Mx3005P® (Stratagene); Nanosep® (Pall Corporation); NASBA® (Organon Teknika); National Comprehensive Cancer Network® (National Comprehensive Cancer Network); NCCN® (National Comprehensive Cancer Network); NEB® (New England Biolabs, Inc.); NEBNext® (New England Biolabs, Inc.); New England Biolabs® (New England Biolabs, Inc.); NeXtal® (Molecular Dimensions, Inc.); NextSeq® (Illumina, Inc.); Norforms® (C.B. Fleet Investment Corporation); NovaSeq® (Illumina, Inc.); Nunc® (Thermo Fisher Scientific or its subsidiaries); Opera™ (Evotec Technologies); Oragene® (DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc.); PAXgene® (PreAnalytiX GmbH); pBluescript® (Stratagene); pGAPase™ (UNIZYME); PIPETMAN® (Gilson Inc.); PIQRAY® (Novartis AG); PPT™ (Becton Dickinson and Company); PrepStain® (Becton Dickinson and Company); PreservCyt® (Hologic, Inc.); Primer Express® (Life Technologies Corporation); Puritan® (Puritan Medical Products Company); Qcyclase™ (UNIZYME); QIAGEN GeneReader® (Intelligent Bio-Systems, Inc.); Remp® (Remp AG); RespiFinder® (PathoFinder BV); Ribo-Zero® (Illumina, Inc.); Roche® (Roche Group); Sarstedt® (Sarstedt AG and Co.); SBTengine® (Genome Diagnostics); SBTexcellerator® (Genome Diagnostics); Schering-Plough® (Merck Sharp & Dohme Corp.); Siemens® (Siemens AG); sign® (Diatech srl); S-Monovette® (Sarstedt AG and Co.); SNaPshot™ (Life Technologies Corporation); SSP™ (Olerup SSP AB Company, Sweden); Starlab® (Starlab Group); SurePath® (Becton Dickinson and Company); SYBR® (Life Technologies Corporation); TaqMan® (Roche Group); Teflon® (E. I. du Pont de Nemours and Company); Terumo® (Terumo Europe N.V.); Thermo Scientific® (Thermo Fisher Scientific or its subsidiaries); Thermo-Fast® (Thermo Fisher Scientific or its subsidiaries); ThinPrep® (Hologic, Inc.); TRACKMAN® (Gilson Inc.); TraXis® (Micronic Holding B.V.); TruSeq® (Illumina, Inc.); Tubersol® (Sanofi Pasteur Ltd.); Vacuette® (Greiner Bio-One GmbH); Vacutainer® (Becton Dickinson and Company); Vagisan™ (Dr. August Wolff, GmbH & Co. KG Arzneimittel); Vagisil® (Combe Incorporated); Vectibix® (Immunex Corporation); Venoject® (Terumo Europe N.V.); Venosafe® (Terumo Europe N.V.); VEROGEN® (Verogen Inc.); Vertex® (Vertex Pharmaceuticals Incorporated); VIC® (Life Technologies Corporation); virotype® (Indical Bioscience GMBH); Whatman® (Whatman International Limited Corporation); Windows® (Microsoft Corporation); Yeast Gard® (TCF National Bank). All other trademarks are the property of their respective owners.

Disclaimers

Registered names, trademarks, etc. used in the QIAGEN website, even when not specifically marked as such, are not to be considered unprotected by law.

External links on this web site are provided only for the convenience of QIAGEN web site visitors. QIAGEN has no interest in, responsibility for, or control over non-QIAGEN affiliated linked sites. QIAGEN makes no promises or warranties of any kind, express or implied, including those of merchantability and fitness for a particular purpose, as to content of linked sites. In no event shall QIAGEN be liable for any damages resulting from use of these links even if QIAGEN has been informed of the possibility of such liability.

Differential display technology is covered by US patent No. 5,262,311 and other pending patents licensed to GenHunter Corporation.

ImmunEasy technology is covered by U.S. Patents 6,194,388 and 6,207,646 exclusively licensed by Coley Pharmaceutical Group, Inc.

The SAGE process is covered by U.S. Patent 5,695,937 owned by Genzyme Molecular Oncology.

TAGZyme technology is licensed under U.S. Patent No. 5,691,169, U.S. Patent No. 5,783, 413, and E.U. Patent No. 00759931B1.

Hoffmann-La Roche owns patents and patent applications pertaining to the application of Ni-NTA resin (in certain countries) and to 6xHis-coding vectors and His-labeled proteins. All purification of recombinant proteins by Ni NTA chromatography for commercial purposes, and the commercial use of proteins so purified, require a license from Hoffmann-La Roche in certain countries.

NOTICE TO PURCHASER: LIMITED LICENCE

'Black Hole Quencher,' 'BHQ', 'CAL Fluor', and Quasar are registered trademarks of Biosearch Technologies, Inc.. Novato, CA. BHQ technology is the subject of US Patent No. 7,019,129, CAL Fluor technology is the subject of US Patent No. 7,344,701, and Quasar dyes are subject to US Patent 7,705,150.

QIAGEN products incorporating the BHQ, CAL Fluor, and Quasar dyes are licensed and sold under agreement with Biosearch Technologies, lnc.

These products are sold for use by the end-user only and may not be re-sold, distributed or repackaged except for authorized OEM Customers.

For products comprising Scorpions Primers:
This product is sold under license from PHRI Properties.

The PAXgene Blood RNA System (cat. nos. 762105, 762115, 762331, and 762134) and the PAXgene Blood DNA System (cat. nos. 761105, 761115, 761125, 761132, and 761133) are for research use only and not for use in diagnostic procedures.

The PAXgene Blood RNA Kit (cat. nos. 762164 and 762174) is for in vitro diagnostic use. Not available in all countries.

The PAXgene Blood RNA MDx Kit (cat. no. 762461) is intended as a general-purpose device for laboratory use. No claim or representation is intended for its use to identify any specific organism or for clinical use (diagnostic, prognostic, therapeutic, or blood banking). It is the user’s responsibility to validate the performance of the PAXgene Blood RNA MDx Kit for any particular use, since the performance characteristics of these kits have not been validated for any specific organism. The performance characteristics of this product have not been fully established.

siRNA technology is licensed to QIAGEN under European Patent 1 144 623 and foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge, USA and is provided only for use in academic and commercial research (excluding the evaluation or characterization of this product as the potential basis for a siRNA-based drug) and not for any other commercial purposes. Information about licenses for commercial use (including discovery and development of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge, MA 02142, USA.

siRNA technology is licensed to QIAGEN from the Massachusetts Institute of Technology under United States Patent Application 09/821,832 and corresponding US and foreign patent applications. siRNA technology is licensed to QIAGEN from the Carnegie Institute of Washington under United States Patent 6,506,559 and corresponding US and foreign patent applications.

"RNAlater®" is a trademark of AMBION, Inc., Austin, Texas and is covered by various U.S. and foreign patents.

RNAlater® may not be re-sold or used for commercial purposes, which both require a specific license.

"Intelli-Plate™" is a trademark of Art Robbins Instruments, LLC.

National Comprehensive Cancer Network®, NCCN®, NCCN GUIDELINES® (National Comprehensive Cancer Network, Inc.). NCCN GUIDELINES® referenced with permission from The NCCN Clinical Practice Guidelines in Oncology® for Colon Cancer V.3.2012. © National Comprehensive Cancer Network, Inc 2012. All rights reserved. Accessed June 15, 2012. To view the most recent and complete version of the guideline, go online to www.nccn.org.

Oregon Green and Texas Red are licensed from Molecular Probes, Inc.

Oligotex products are not available in Japan.

Strep-tag technology for protein purification and detection is covered by US patent 5,506,121, UK patent 2272698 and French patent 93 13 066; Strep-Tactin is covered by US patent 6,103,493.

The QIAGEN BioRobot MDx DSP workstation and QIAamp DSP kits comply with EU Directive 98/79/EC on in vitro diagnostic medical devices. Other (non-DSP) QIAGEN workstations and kits are intended as general-purpose devices. No claim or representation is intended for their use to identify any specific organism or for a specific clinical use (diagnostic, prognostic, therapeutic, or blood banking). It is the user’s responsibility to validate the performance of QIAGEN non-DSP workstations and kits for any particular use, since their performance characteristics have not been validated for any specific organism. QIAGEN non-DSP workstations and kits may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system as required by CLIA '88 regulations in the U.S. or equivalents in other countries.

QIAGEN REPLI-g Kits are for use only as licensed by Amersham Biosciences Corp (part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi 29 DNA polymerase may not be re-sold or used except in conjunction with the other components of this kit. The REPLI-g Kit is developed, designed, and sold for research purpose only.

Benzonase® Nuclease is supplied by Merck KGaA and its Affiliates. Benzonase® is a registered trademark of Merck KGaA, Darmstadt, Germany.

The QuantiTect Whole Transcriptome Kit is for use only as licensed by Amersham Biosciences Corp (part of GE Healthcare Bio-Sciences) and QIAGEN GmbH. The Phi 29 DNA polymerase may not be re-sold or used except in conjunction with the other components of this kit. The QuantiTect Whole Transcriptome Kit is developed, designed, and sold for research purpose only.

This multiplex PCR product is licensed under US5,582,989 and corresponding patents.

SBTexcellerator HLA Kits are licensed from Genome Diagnostics BV. QIAGEN acts as a co-exclusive distributor of SBTengine software.

The NeuMoDx™ 96 Molecular System and the NeuMoDx™ 288 Molecular System are covered by U.S. Patent Nos. 7,998,708; 8,323,900; 8,415,103; 8,709,787; 10,494,663; 10,364,456; 10,443,088; 10,604,788; 10,625,261; 10,625,262; and 10,632,466 owned by HandyLab, Inc. (an affiliate of Becton, Dickinson and Company).

QuantiFast SYBR Green PCR Kit, QuantiTect SYBR Green PCR Kit, QuantiFast SYBR Green RT-PCR Kit, QuantiTect SYBR Green RT-PCR Kit, FastLane Cell SYBR Green Kit, and miScript SYBR Green PCR Kit

Use of this product is covered by one or more of the following US patents and corresponding patent claims outside the US: 5,994,056 and 6,171,785. The purchase of this product includes a limited, nontransferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser's own internal research. No right under any other patent claim and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel. This product is for research use only. Diagnostic uses under Roche patents require a separate license from Roche. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.

QuantiTect SYBR Green PCR Kit, QuantiTect SYBR Green RT-PCR Kit, QuantiTect Probe PCR Kit, QuantiTect Probe RT-PCR Kit, QuantiTect Multiplex PCR Kits, QuantiTect Multiplex RT-PCR Kits, FastLane Cell SYBR Green Kit, FastLane Cell Probe Kit, FastLane Cell Multiplex Kits, and miScript SYBR Green PCR Kit
NOTICE TO PURCHASER: LIMITED LICENSE

The use of this product is covered by at least one claim of U.S. Patent No. 7,687,247 owned by Life Technologies Corporation. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot sell or otherwise transfer (a) this product, (b) its components, or (c) materials made by the employment of this product or its components to a third party or otherwise use this product or its components or materials made by the employment of this product or its components for Commercial Purposes. Commercial Purposes means any activity for which a party receives or is due to receive consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. The buyer cannot use this product or its components or materials made using this product or its components for therapeutic, diagnostic or prophylactic purposes. Further information on purchasing licenses under the above patents may be obtained by contacting the Licensing Department, Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, CA 92008. Email: outlicensing@lifetech.com.

QuantiTect Primer Assays and miScript Primer Assays

No license is conveyed with the purchase of this product under any ofUS Patents Nos. 5,804,375, 5,994,056, 6,171,785, 5,538,848, 5,723,591, 5,876,930, 6,030,787, and 6,258,569, and corresponding patents ontside the United States, or any other patents or patent applications, relating to the 5' Nuclease and dsDNA-Binding Dye Processes. For further information contact the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.

QuantiTect Custom Assays

Purchase of this product carries with it a limited, non-transferable, non-exclusive (without the right to resell, repackage, or sublicense) license under U.S. Patent Nos. 6,030,787; 5,723,591; and 5,876,930, and corresponding foreign patents. No other license under these patents or any other patents is granted expressly, impliedly, or by estoppel. No license under the PCR process is conveyed through purchase of this product. This limited license permits the person or legal entity to which this product has been provided to use the product, and the data generated by use of the product, only for its internal research purposes involving hybridization-based analysis of nucleic acids in the ordinary course of Buyer’s normal internal research and development activities within the life sciences field (including without limitation, drug discovery, drug development, medical research, fermentation research and agricultural research). The product may not be used for any other commercial, clinical, diagnostic or any other use, including, without limitation any human or animal diagnostic uses (including any use of the results of any testing performed with this product in making therapeutic or treatment decisions for a patient), industrial (including food industry) testing, forensic testing, environmental testing (including bio-terrorism and bio-warfare), or any use of these products to provide services of any kind. Buyer agrees and understands it is not licensed to (a) provide commercial data or databases to or on behalf of any third party that relate to use of the product; or (b) use the product or data there from in a clinical diagnostic setting where data from an individual’s sample is given to such individual or their caregiver. Neither Nanogen nor its licensors grants any other licenses, express or implied, to permit the manufacture, use, sale, or importation of the product, any other nucleic acids, or any data generated from use of the product. This product or portions hereof are subject to proprietary rights of Nanogen, Inc. and this product is made and sold under license from Nanogen under Nanogen’s patents and patent applications and there is no implied license for any other use with respect to this product. A license must be obtained directly from Nanogen with respect to any other proposed use of this product.

For products comprising ROX dye

The purchase of this product includes a limited, non-transferable right to use the purchased amount of the product to perform Applied Biosystems’ patented Passive Reference Method for the purchaser’s own internal research. No right under any other patent claim and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel. This product is for research use only. For information on obtaining additional rights, please contact outlicensing@lifetech.com or Out Licensing, Life Technologies, 5791 Van Allen Way, Carlsbad, California 92008.

Rotor-Gene Q

For applicable countries:
The purchase of this product includes a limited, non-transferable license to one or more of US Patents Nos 6,787,338; 7,238,321; 7,081,226; 6,174,670; 6,245,514; 6,569,627; 6,303,305; 6,503,720; 5,871,908; 6,691,041; 7,387,887; and U.S. Patent Applications Nos. 2003-0224434 and 2006- 0019253 and all continuations and divisionals, and corresponding claims in patents and patent applications outside the United States, owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, for internal research use or for non-in vitro diagnostics applications. No right is conveyed, expressly, by implication or estoppel, for any reagent or kit, or under any other patent or patent claims owned by the University of Utah Research Foundation, Idaho Technology, Inc., and/or Roche Diagnostics GmbH, or by any other Party. For information on purchasing licences for in-vitro diagnostics applications or reagents, contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.

For applicable countries:
This real-time thermal cycler is licensed under pending U.S. Patent rights for an apparatus or system covering automated thermal cyclers with fluorescence detectors and seeking priority to U.S. Serial No. 07/695,201 and corresponding claims in any foreign counterpart patent thereof owned by Applied Biosystems LLC, in all fields, including research and development, all applied fields, and human and animal in-vitro diagnostics. No rights are conveyed expressly, by implication or estoppel to any patents on real-time methods, including but not limited to 5‘ nuclease assays, or to any patent claiming a reagent or kit. For further information on purchasing additional rights, contact the Director of Licensing at Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California, 94404, USA.

Rotor-Gene Q MDx

For applicable countries:
The purchase of this product includes a limited, non-transferable license to one or more of U.S. Patent Nos. 6,787,338; 7,238,321; 7,081,226; 6,174,670; 6,245,514; 6,569,627; 6,303,305; 6,503,720; 5,871,908; 6,691,041; 7,387,887; 7,273,749; 7,160,998; U.S. Patent Application Nos. 2003-0224434 and 2006-0019253, and PCT Patent Application No. WO 2007/035806, and all continuations and divisionals, and corresponding claims in patents and patent applications outside the United States, owned by the University of Utah Research Foundation, Idaho Technology, Inc., Evotec Biosystems GmbH, and/or Roche Diagnostics GmbH for human or animal in-vitro diagnostics only. No right is conveyed, expressly, by implication or estoppel, for any reagent or kit, or under any other patent or patent claims owned by the University of Utah Research Foundation, Idaho Technology, Inc., Roche Diagnostics GmbH, or by any other Party. This product may be operated only with authorized reagents such as fully licensed QIAGEN kits and assays. For information on purchasing licenses for in-vitro diagnostics applications or reagents, please contact Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588, USA.

EpiTect Methyl qPCR Arrays, EpiTect Methyl qPCR Assays, and EpiTect Methyl DNA Restriction Kit

Purchaser agrees that use of this product and data therefrom is limited solely to the purchaser and for only the purchaser’s own internal molecular biology research applications (“Permitted Use”), and shall not be re-sold or used for any other purposes (all of which are expressly prohibited), including without limitation diagnostic purposes, uses that could require regulatory approval for diagnostics from an agency of any government or regulatory entity anywhere in the world, diagnosis, prevention, or treatment of disease, and the right to perform commercial services of any kind, including without limitation, reporting the results of purchaser’s activities, including without limitation, for a fee or other commercial consideration. Except for the Permitted Use, no rights, titles, or interests in or to any tangible or intangible property rights are conveyed or shall be deemed conveyed by implication, estoppel or otherwise. The performance characteristics of the product other than for the Permitted Use are unknown.

QuantiFERON-TB Gold Plus

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus package inserts, up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.